Intracoronary Vasoactive Therapy for No-Reflow During Primary PCI
In this network meta-analysis, intracoronary verapamil and epinephrine were associated with improvements in final TIMI flow grade 3 compared with control. Further studies are needed to clarify optimal agent selection.
Authors
- Fatih Arslan (ORCID: https://orcid.org/0000-0001-6598-8599)
- Lorenzo Tua
- Brian O. Bingen (ORCID: https://orcid.org/0000-0002-4986-8623)
- Marco Ferlini (ORCID: https://orcid.org/0000-0002-5554-3577)
- Francesco Maria Sparasci (ORCID: https://orcid.org/0009-0009-7154-7621)
- Luca Raone (ORCID: https://orcid.org/0009-0001-6216-7741)
- M Vannucchi Alessandro
- Federico Oliveri
- Jose’ M. Montero-Cabezas
- Leonardo De Luca
Institutions
- Leiden University Medical Center (NL)
- Policlinico San Matteo Fondazione (IT)
- Ospedale Vito Fazzi (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1016/j.jacadv.2026.102599
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00